Dr. Willmott on FDA Approval of Maintenance Olaparib in Ovarian Cancer
August 17th 2017Lyndsay J. Willmott, MD, a gynecologic oncologist with Arizona Oncology, discusses the FDA approval of olaparib (Lynparza) in the maintenance setting for relapsed patients with platinum-sensitive ovarian cancer.
Read More